Clinical research using iPS cells approved

Clinical research using iPS cells approved

TOKYO, Japan - Members of a health ministry panel hold a meeting in Tokyo on June 26, 2013, on whether to approve the world's first clinical research using human induced pluripotent stem cells, known as iPS cells, which can grow into any type of human tissue. The panel approved a clinical research plan by the Riken governmental scientific research institute and the Foundation for Biomedical Research and Innovation to use iPS cells for regenerating retinas.

  • Product Code
  • ILEA001183977
  • Registered date
  • 2013/6/26 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 2874 × 1954 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 586.07(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    World's 1st iPS cell transplant

    World's 1st iPS cell transplant

    KOBE, Japan - The operation room of the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan, is seen on Sept. 10, 2014. The world's first surgery to implant retinal tissue derived from induced pluripotent stem cells into a human body was performed there in September 2014.
      World's 1st transplant surgery using iPS cells conducted

      World's 1st transplant surgery using iPS cells conducted

      KOBE, Japan - Photo taken Sept. 10, 2014, shows the Institute of Biomedical Research and Innovation Hospital in Kobe, western Japan. At the hospital on Sept. 12, a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s, marking the first time iPS-derived cells have been introduced into a human body by surgery.
        Photo of Riken Kobe Branch buildings

        Photo of Riken Kobe Branch buildings

        KOBE, Japan - This photo taken from a Kyodo News helicopter on March 19, 2014, shows a set of Riken Kobe Branch buildings (C) and the Institute of Biomedical Research and Innovation (back R) in Kobe, western Japan.
          New method for reprogramming body cells

          New method for reprogramming body cells

          TOKYO, Japan - Photo shows Haruko Obokata, a scientist at Riken's Center for Developmental Biology in Kobe. A team of scientists led by Obokata has discovered, in research conducted by scientists at the state-backed Riken institute and Harvard University, that by simply exposing body cells to acidic liquids, the cells can be reprogrammed to grow into any type of mature tissue. They named the method of generating pluripotent cells, or cells that can grow into any type of mature tissues in the body, "stimulus-triggered acquisition of pluripotency," or STAP. The discovery was announced in the Jan. 30, 2014 issue of Nature.
            New method for reprogramming body cells

            New method for reprogramming body cells

            KOBE, Japan - Photo shows Haruko Obokata, a scientist at Riken Center for Developmental Biology in Kobe, wearing an apron given to her by her grandmother at its laboratory in Kobe, Hyogo Prefecture, on Jan. 28, 2014. A team of scientists led by Obokata has discovered, in research conducted by scientists at the state-backed Riken institute and Harvard University, that by simply exposing body cells to acidic liquids, the cells can be reprogrammed to grow into any type of mature tissue. They named the method of generating pluripotent cells, or cells that can grow into any type of mature tissues in the body, "stimulus-triggered acquisition of pluripotency," or STAP. The discovery was announced in the Jan. 30, 2014 issue of Nature.
              New method for reprogramming body cells

              New method for reprogramming body cells

              KOBE, Japan - Haruko Obokata, a scientist at Riken's Center for Developmental Biology in Kobe, speaks on "stimulus-triggered acquisition of pluripotency," or STAP, a method of generating pluripotent cells, in Kobe, Hyogo Prefecture, on Jan. 28, 2014. A team of scientists led by Obokata has discovered, in research conducted by scientists at the state-backed Riken institute and Harvard University, that by simply exposing body cells to acidic liquids, cells can be reprogrammed to grow into any type of mature tissue.
                New method for reprogramming body cells

                New method for reprogramming body cells

                KOBE, Japan - Haruko Obokata, a scientist at Riken's Center for Developmental Biology in Kobe, answers a question at a press conference in Kobe, Hyogo Prefecture, on Jan. 28, 2014, on "stimulus-triggered acquisition of pluripotency," or STAP, a method of generating pluripotent cells. A team of scientists led by Obokata has discovered, in research conducted by scientists at the state-backed Riken institute and Harvard University, that by simply exposing body cells to acidic liquids, the cells can be reprogrammed to grow into any type of mature tissue.
                  Clinical research using iPS cells approved

                  Clinical research using iPS cells approved

                  TOKYO, Japan - File photo taken in February 2013 shows Masayo Takahashi (2nd from L), an ophthalmologist who heads Riken's research team on retinal regeneration, and other researchers seeing an experiment on cultured stem cells in Kobe, Hyogo Prefecture. On June 26, 2013, a Japanese government panel approved a clinical research plan by the Riken governmental scientific research institute and the Foundation for Biomedical Research and Innovation to use human induced pluripotent stem cells, known as iPS cells, for regenerating retinas. It would be the world's first clinical research using iPS cells that can grow into any type of human body tissue.
                    Researcher Moriguchi returns to Japan

                    Researcher Moriguchi returns to Japan

                    TOKYO, Japan - Researcher Hisashi Moriguchi (C) meets the press at JR Tokyo Station on Oct. 15, 2012, after returning to Japan from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.